Abilify and Nicotinamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Nicotinamide (niacin and niacinamide (vitamin b3)). Common drug interactions include drug withdrawal syndrome among females and cardiomyopathy among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Nicotinamide. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
What is Nicotinamide?
Nicotinamide has active ingredients of niacin and niacinamide (vitamin b3). eHealthMe is studying from 1,991 Nicotinamide users. Check the latest studies of Nicotinamide.
18 people who take Abilify and Nicotinamide together, and have interactions are studied.

What are the common drug interactions of Abilify and Nicotinamide, by gender? *:
female:
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Malaise (a feeling of general discomfort or uneasiness)
- Abnormal behaviour
- Electrolyte imbalance
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Alanine aminotransferase increased
- Pneumonia
- Productive cough
male:
- Cardiomyopathy (weakening of the heart muscle)
- Hepatic congestion (liver congestion)
- Personality change
- Platelet count increased
- White blood cell count increased
- Hepatic steatosis (fatty liver disease)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Agitation (state of anxiety or nervous excitement)
- Concussion (short loss of normal brain function in response to a head injury)
- Drug abuse
What are the common drug interactions of Abilify and Nicotinamide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Hepatic steatosis (fatty liver disease)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Agitation (state of anxiety or nervous excitement)
- Concussion (short loss of normal brain function in response to a head injury)
- Drug abuse
- Head injury
- Loss of consciousness
- Memory impairment
- Personality change
- Platelet count increased
40-49:
n/a
50-59:
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Malaise (a feeling of general discomfort or uneasiness)
- Abnormal behaviour
- Electrolyte imbalance
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Alanine aminotransferase increased
- Pneumonia
- Productive cough
60+:
n/a
What are the existing conditions these people have? *
- High Blood Pressure: 6 people, 33.33%
- Post Laminectomy Syndrome: 5 people, 27.78%
- Pain: 5 people, 27.78%
- Neuralgia (pain in one or more nerves): 5 people, 27.78%
- Neck Pain: 5 people, 27.78%
- Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)): 5 people, 27.78%
- Bipolar Disorder (mood disorder): 2 people, 11.11%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.56%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 5.56%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Nicotinamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Abilify (101,454 reports)
- Nicotinamide (1,991 reports)
Browse all drug interactions of Abilify and Nicotinamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nicotinamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nicotinamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and niacin and niacinamide (vitamin b3) (the active ingredients of Abilify and Nicotinamide, respectively), and Abilify and Nicotinamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Depo-Provera and Botox - now
- Drug interactions of Mesna and Allopurinol - 5 seconds ago
- Could Famotidine cause Infusion Site Irritation? - 18 seconds ago
- Could Oxycodone Hydrochloride cause Skin Disorder? - 22 seconds ago
- Drug interactions of Prevacid 24 Hr and Xarelto - 24 seconds ago
- Could Biotin cause Oxygen Saturation Decreased? - 27 seconds ago
- Could Bisacodyl cause Renal Disorder? - 29 seconds ago
- Menopausal Symptoms and Vaginal Bleeding Between Periods - 33 seconds ago
- Could Venlafaxine Hydrochloride cause Scab? - 37 seconds ago
- Drug interactions of Allopurinol and Epanova - 40 seconds ago